BLOG

A Journey: Biotech, FDA, and Safety Committee Responses to COVID

Sudarshan Hebbar, CMO of CalciMedica, reveals how the FDA, ethics committees, and safety consortia have responded to helping to advance the application of novel therapeutics towards COVID.